Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

38.9K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.9K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

3.4K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

10.4K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.8K
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic radiation drives leptomeningeal dissemination of medulloblastoma through an innate immune process.

Developmental cell·2025
Same author

Targeting synthetic lethality between non-homologous end joining and radiation in very-high-risk medulloblastoma.

Cell reports. Medicine·2025
Same author

Metastatic medulloblastoma remodels the local leptomeningeal microenvironment to promote further metastatic colonization and growth.

Nature cell biology·2025
Same author

Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres.

Cells·2025
Same author

Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres.

bioRxiv : the preprint server for biology·2024
Same author

Leading medulloblastoma to a differentiation end.

Cancer cell·2024

Related Experiment Video

Updated: Mar 28, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.7K

p53 and Meduloblastoma.

Vijay Ramaswamy1, Carolina Nör2, Michael D Taylor3

  • 1Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A1, Canada Program in Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.

Cold Spring Harbor Perspectives in Medicine
|December 20, 2015
PubMed
Summary

TP53 mutations significantly impact medulloblastoma patient outcomes, particularly in Sonic Hedgehog subgroup tumors. Understanding p53

More Related Videos

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.9K
Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.2K

Related Experiment Videos

Last Updated: Mar 28, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.7K
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.9K
Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.2K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Medulloblastoma biology is complex, with significant intertumoral heterogeneity.
  • The role of p53 in medulloblastoma has been increasingly recognized over the past two decades.
  • Recent advances highlight the significance of TP53 mutations, especially within specific molecular subgroups.

Purpose of the Study:

  • To review the current understanding of p53's role in medulloblastoma.
  • To explore the impact of TP53 mutations on medulloblastoma heterogeneity and patient risk stratification.
  • To summarize recent findings on p53's involvement in medulloblastoma treatment resistance.

Main Methods:

  • Review of recent integrated genomics studies.
  • Analysis of molecular subgroup classifications in medulloblastoma.
  • Synthesis of current literature on p53 function and TP53 mutations in medulloblastoma.

Main Results:

  • TP53 mutation significance is highly dependent on the medulloblastoma molecular subgroup.
  • TP53-mutant Sonic Hedgehog medulloblastomas represent an extremely high-risk patient group.
  • There is a growing focus on understanding p53's role in treatment resistance.

Conclusions:

  • Intertumoral heterogeneity, particularly concerning TP53 mutations, is critical for understanding medulloblastoma.
  • TP53 mutations are key determinants of risk and treatment response in specific medulloblastoma subtypes.
  • Further research into p53's function is essential for improving medulloblastoma treatment strategies.